KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Work In Process (2016 - 2026)

Supernus Pharmaceuticals has reported Work In Process over the past 13 years, most recently at $29.4 million for Q4 2025.

  • Quarterly Work In Process rose 10.14% to $29.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $29.4 million through Dec 2025, up 10.14% year-over-year, with the annual reading at $29.4 million for FY2025, 10.14% up from the prior year.
  • Work In Process was $29.4 million for Q4 2025 at Supernus Pharmaceuticals, down from $33.4 million in the prior quarter.
  • Over five years, Work In Process peaked at $46.2 million in Q1 2022 and troughed at $9.3 million in Q1 2021.
  • The 5-year median for Work In Process is $27.5 million (2023), against an average of $28.1 million.
  • Year-over-year, Work In Process soared 408.75% in 2021 and then tumbled 36.0% in 2023.
  • A 5-year view of Work In Process shows it stood at $45.7 million in 2021, then tumbled by 30.63% to $31.7 million in 2022, then dropped by 1.57% to $31.2 million in 2023, then dropped by 14.38% to $26.7 million in 2024, then grew by 10.14% to $29.4 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Work In Process are $29.4 million (Q4 2025), $33.4 million (Q3 2025), and $15.6 million (Q2 2025).